The association between gut microbiome affecting concomitant medication and the effectiveness of immunotherapy in patients with stage iv nsclc

HIGHLIGHTS

  • who: M. V. Verschueren from the DepartmentThe NetherlandsUtrecht University have published the research: The association between gut microbiome affecting concomitant medication and the effectiveness of immunotherapy in patients with stage IV NSCLC, in the Journal: Scientific Reports Scientific Reports of 12/Nov/2021
  • what: The study has a number of notable strengths.

SUMMARY

    The Netherlands Cancer Registry (NCR) was used for identifying all patients diagnosed with NSCLC in a Santeon hospital, and for obtaining information on the date of diagnosis and the vital status. The patients` medical records were used to . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?